aspirin
Selected indexed studies
- Low-dose aspirin for the prevention of atherosclerotic cardiovascular disease. (Eur Heart J, 2024) [PMID:38839268]
- Aspirin in Primary Prevention of Cardiovascular Events. (Clin Med Res, 2020) [PMID:32580960]
- Aspirin in the Modern Era of Cardiovascular Disease Prevention. (Methodist Debakey Cardiovasc J, 2021) [PMID:34824680]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Low-dose aspirin for the prevention of atherosclerotic cardiovascular disease. (2024) pubmed
- Aspirin in Primary Prevention of Cardiovascular Events. (2020) pubmed
- Aspirin in the Modern Era of Cardiovascular Disease Prevention. (2021) pubmed
- Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial. (2018) pubmed
- Aspirin sensitivity of PIK3CA-mutated Colorectal Cancer: potential mechanisms revisited. (2022) pubmed
- Aspirin nanosensors. (2025) pubmed
- Aspirin and its pleiotropic application. (2020) pubmed
- Aspirin in the Prevention of Colorectal Neoplasia. (2021) pubmed
- Aspirin is associated with improved outcomes in patients with sepsis-induced myocardial injury: An analysis of the MIMIC-IV database. (2024) pubmed
- Aspirin for the extended prevention of venous thromboembolism: a meta-analysis and trial sequential analysis. (2025) pubmed